Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols
NCT ID: NCT00834548
Last Updated: 2009-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2008-06-30
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our hypothesis is that use of a new protocol improves the diagnostic quality of the WB-MRA procedure.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whole Body Magnetic Resonance Angiography in Ischemic Patients
NCT00538408
Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T
NCT00554073
Patient Acceptance of Whole Body Magnetic Resonance Angiography
NCT00556101
Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis
NCT00001946
Magnetic Resonance Angiography (MRA) for the Diagnosis of Atherosclerosis
NCT00001841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
WB-MRA is an imaging procedure that can visualise the arterial system. WB-MRA can be performed in different manners. On option is to start the scan in the head region and continue down the body to the feet (standard protocol). Another option is to use a hybrid protocol that first examines the head and lower leg followed by examination of the pelvic and upper leg region.
A comparison between the standard and hybrid protocols has not been performed in a 3T high magnetic field system, therefore we will perform such a study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
WB-MRA standard protocol
Whole body magnetic resonance angiography (WB-MRA)
WB-MRA will be performed once in each patient.
2
WB-MRA hybrid protocol
Whole body magnetic resonance angiography (WB-MRA)
WB-MRA will be performed once in each patient.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole body magnetic resonance angiography (WB-MRA)
WB-MRA will be performed once in each patient.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred to digital subtraction angiography (DSA)
Exclusion Criteria
* Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker)
* Dementia
* Pregnancy/lactation
* Allergy to gadolinium based MRI contrast agents
* Acute disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Copenhagen University Hospital at Herlev
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Copenhagen University Hospital Herlev
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yousef W Nielsen, MD
Role: PRINCIPAL_INVESTIGATOR
Copenhagen University Hospital at Herlev
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital Herlev
Herlev Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Herlev WB-MRA 5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.